Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MEXICAN ECONOMIC DEVELOPMENT INC (FMX)

  • Business News
  • June 08, 2026, 12:50 UTC
  • 3
  • 1 comments

QED invertirá en el negocio de crédito de FEMSA

Market reaction Comment Full text

MEXICAN ECONOMIC DEVELOPMENT INC (FMX)

  • Business News
  • June 08, 2026, 12:50 UTC
  • 3
  • 1 comments

QED to invest in FEMSA’s lending venture

Market reaction Comment Full text

ASPIAL LIFESTYLE LIMITED (5UF)

  • Business News
  • June 08, 2026, 12:46 UTC
  • 2
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes in Interest of Director - Koh Wee Seng

Market reaction Comment Full text

NEXTAGE THERAPEUTICS LTD (NXTG)

  • Business News
  • June 08, 2026, 12:46 UTC
  • 3
  • 1 comments

Net Asset Value(s)

Market reaction Comment Full text

PPG INDUSTRIES INC (PPG)

  • Business News
  • June 08, 2026, 12:41 UTC
  • 3
  • 1 comments

PPG appoints John Smith to vice president, architectural coatings EMEA; Steve Pocock to retire

Market reaction Comment Full text

WIMI HOLOGRAM CLOUD INC. (WiMi)

  • Business News
  • June 08, 2026, 12:40 UTC
  • 3
  • 1 comments

WiMi Explores Multi-Dimensional Pooling Optimization Technology under the Variational Quantum Algorithm Framework

Market reaction Comment Full text

VCI GLOBAL LTD (VCIG)

  • Business News
  • June 08, 2026, 12:39 UTC
  • 3
  • 1 comments

V Gallant’s Fintech Partner Credilab Secures Full Online Lending Approval in Malaysia, Advancing Revenue-Share AI Lending Platform

Market reaction Comment Full text

JEFFS'' BRANDS LTD (NEXR)

  • Business News
  • June 08, 2026, 12:36 UTC
  • 3
  • 1 comments

Nexera Technologies: Subsidiary Fort Technology Commences Trading on Nasdaq Under Ticker “FRTT” Today

Market reaction Comment Full text

AIM ImmunoTech Inc. (AIM)

  • Business News
  • June 08, 2026, 12:33 UTC
  • 3
  • 1 comments

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZenecas Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Market reaction Comment Full text

FORESIGHT AUTONOMOUS HOLDINGS LTD (FRSX)

  • Business News
  • June 08, 2026, 12:33 UTC
  • 3
  • 1 comments

Foresight Secures $17.5 Million Strategic Investment from VisionWave at a $34 Million Valuation Post Investment to Advance AI Perception Capabilities for Defense and Security

Market reaction Comment Full text
  • Previous
  • 2529
  • 2530
  • 2531
  • 2532
  • 2533
  • Next

Search

News categories

  • Technical Exchange News(14009)
  • Event(6229)
  • SEC News(356634)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(216006)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin